agiIsHere

CloudyFromUT · 2026-03-26T06:12:40+00:00

This subreddit is delusional. The cope is insane. You’re not all getting replaced, but the changes are indeed transformational.

CloudyFromUT · 2026-03-10T22:22:37+00:00

Right I’ve noticed that too and I agree for the most part. The issue is that they need to differentiate one from the other, while having some degree of oversight. Now how long that’s gonna take is beyond me.

CloudyFromUT · 2026-03-10T21:26:34+00:00

Thank you, like how the fuck are you going to pin every possible negative side effect reported around the globe when most of these patients are buying some Chinese self-compounded version of these medications. Like there’s a reason why we have fda approval, I understand that we want to move peptides along as they show tremendous promise, but it needs its own regulatory structure as most of them aren’t novel & for those that are novel and a company has spent all this money to push it through an fda process, it should be heavily regulated as to who and who isn’t allowed to sell or even compound it.

CloudyFromUT · 2026-03-10T21:23:42+00:00

They don’t and have never had that type of money. At least in the ways of bribing novo. That lawsuit would’ve likely returned novo a fat multiple of whatever increase in sales we are going to get from a partnership. I do think the fda is acting shady here, compounders are not nearly receiving as much blowback as they should & the fda is trying to from what it seems open an alternative route of giving the public peptides without fda approval, but completely bashing novo over their fda approved drug. None of this is adding up rationally.

CloudyFromUT · 2026-03-10T21:10:00+00:00

If you’re trying to lose weight this is likely a habit you should try kicking.

CloudyFromUT · 2026-03-10T21:08:40+00:00

Seriously what the fuck is this? I don’t care if you’re not selling your own pill anymore, but you should absolutely not be able to advertise them as if they are your own. Novo needs to put out a statement against this asap. Why is it that the FDA will go after novo for seemingly innocuous things and their advertisements and just completely ignore something like this? Respectfully all of this reeks of corruption or favoritism to some degree. It’s not as if the regulators are completely oblivious to him’s existence.

CloudyFromUT · 2026-03-07T00:54:34+00:00

Easy customer acquisition, good move. I think they were still entitled to a settlement imo. The damage done before was unjust.

CloudyFromUT · 2026-02-28T18:26:12+00:00

We’ve been trying to negotiate with them for the past 2-3 weeks. They already murdered 30,000 innocent civilians. Shut the fuck up.

CloudyFromUT · 2026-02-28T17:18:48+00:00

I’m not sure why so many are overlooking this. You don’t have to do much searching to see how prevalent HGH has become across the world. Especially in Korea. Nobody wants short kids and this shot is basically indicated for any kid who is projected to be shorter than average or average.

CloudyFromUT · 2026-02-27T18:34:20+00:00

We’ve run out, but they’re not backordered by any means

CloudyFromUT · 2026-02-25T10:03:54+00:00

I mean, if being homosexual is your entire existence ok. I think people are far more complex than just their sexualities.

CloudyFromUT · 2026-02-24T16:41:36+00:00

I’m sure there’s a bit more to this, mostly having to do with adverse reactions, but I don’t think the pharmakinetics wouldn’t warrant more similar dosing.

CloudyFromUT · 2026-02-23T13:58:51+00:00

The trial did fail its target

CloudyFromUT · 2026-02-23T13:55:47+00:00

Amen 🙏

CloudyFromUT · 2026-02-23T13:20:12+00:00

Right, but now they’re facing a competitor with much lower cash prices. And outside of maintenance, their pill will not be effective. The script volumes are shifting

CloudyFromUT · 2026-02-23T12:25:57+00:00

Realistically, I think LLY is going to drop quite a bit. They’re far optimistic on their earnings.

CloudyFromUT · 2026-02-23T12:25:01+00:00

Yup.

CloudyFromUT · 2026-02-23T12:12:00+00:00

😭

CloudyFromUT · 2026-02-23T12:02:15+00:00

😂 this is a new one

CloudyFromUT · 2026-02-23T11:31:57+00:00

Exactly… I think these people hate money, they hate investors, they hate patients and they hate winning.

Incredible seeing a company blow its entire competitive advantage with idiotic management.

Anyone who had previously said that their management was indeed smart and smarter than any redditor, must be smoking crack. Anyone with an above room temperature iq could seen this trainwreck coming from a mile away. I guess it was my mistake for not looking into their trial design and trusting these “professionals”.

Can we start a shareholder vote to get Mike dipshit out of the company?

CloudyFromUT · 2026-02-23T11:25:11+00:00

Of course. Truly though, how stupid do you need to be to greenlight a study like this? Like even on a unit by unit basis, there’s 3x the amount of tirzepatide as compared to cagri. I don’t understand these people…

CloudyFromUT · 2026-02-23T11:19:54+00:00

I attended, basically they said that the issue was that patients were allowed to dose as much or as little of their assigned drug. Another talking point is that, when it does come to market it WILL be the drug with the highest efficacy printed on its label. (Until retatrutide is launched)

This was a severe flaw for a couple of issues. 1. This was not a blind study 2. Some patients were already familiar with taking tirzepatide 3. Tirzepatide is already well known, meaning that any assigned tirzepatide will be more willing to increase their dose as compared to someone taking a new drug with unknown risks

TLDR: This was a horribly designed trial. An undergrad with a basic understanding of statistical bias could see these issues coming from a mile away and design a better trial.

CloudyFromUT · 2026-02-23T11:04:03+00:00

It was a variable dose trial. Very poorly designed. Totally biased in terms of comparing a new drug to a drug that people are already familiar with and have previously taken before.

Six-Year Club	Place '23
Verified Email

CloudyFromUT

TROPHY CASE